Line 1: |
Line 1: |
| + | The following list is based on the 2016 [http://cancer.sanger.ac.uk/census/ Sanger Centre Cancer Gene Census]. |
| + | |
| {| class="wikitable sortable" | | {| class="wikitable sortable" |
| |- | | |- |
| ! Gene Symbol !! Chromosome Band !! Cancer Syndrome !! Tumour Types Arising | | ! Gene Symbol !! Chromosome Band !! Cancer Syndrome !! Tumour Types Arising |
| |- | | |- |
− | |ALK || 2p23 || familial neuroblastoma || neuroblastoma | + | |[[ALK]]||2p23||[[familial neuroblastoma]]||[[neuroblastoma]] |
| |- | | |- |
− | |APC || 5q21 || adenomatous polyposis coli; Turcot syndrome || colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS | + | |[[APC]]||5q21||[[adenomatous polyposis coli; Turcot syndrome]]||[[colorectal]],[[ pancreatic]],[[ desmoid]],[[ hepatoblastoma]],[[ glioma]],[[ other CNS]] |
| |- | | |- |
− | |ATM || 11q22.3 || ataxia-telangiectasia || leukaemia, lymphoma, medulloblastoma, glioma | + | |[[ATM]]||11q22.3||[[ataxia-telangiectasia]]||[[leukaemia]],[[ lymphoma]],[[ medulloblastoma]],[[ glioma]] |
| |- | | |- |
− | |ATR || 3q23 || familial cutaneous telangiectasia and cancer sydrome || oropharyngeal | + | |[[ATR]]||3q23||[[familial cutaneous telangiectasia and cancer sydrome]]||[[oropharyngeal]] |
| |- | | |- |
− | |AXIN2 || 17q24.1 || oligodontia-colorectal cancer syndrome || colorectal carcinoma | + | |[[AXIN2]]||17q24.1||[[oligodontia-colorectal cancer syndrome]]||[[colorectal carcinoma]] |
| + | |- |
| + | |[[BAP1]]||3p21.31-p21.2|| ||[[mesothelioma]],[[ uveal melanoma]] |
| + | |- |
| + | |[[BLM]]||15q26.1||[[Bloom syndrome]]||[[leukaemia]],[[ lymphoma]],[[ skin squamous cell]],[[ other tumour types]] |
| + | |- |
| + | |[[BMPR1A]]||10q22.3||[[juvenile polyposis]]||[[gastrointestinal polyps]] |
| + | |- |
| + | |[[BRCA1]]||17q21||[[hereditary breast/ovarian cancer]]||[[breast]],[[ ovarian]] |
| + | |- |
| + | |[[BRCA2]]||13q12||[[hereditary breast/ovarian cancer]]||[[breast]],[[ ovarian]],[[ pancreatic]],[[ leukaemia (FANCB]],[[ FANCD1)]] |
| + | |- |
| + | |[[BRIP1]]||17q22||[[Fanconi anaemia J]],[[ breast cancer susceptiblity]]||[[AML]],[[ leukaemia]],[[ breast]] |
| + | |- |
| + | |[[BUB1B]]||15q15||[[mosaic variegated aneuploidy]]||[[rhabdomyosarcoma]] |
| + | |- |
| + | |[[CDC73]]||1q21-q31||[[hyperparathyroidism-jaw tumour syndrome]]||[[parathyroid adenoma]],[[ multiple ossifying jaw fibroma]] |
| + | |- |
| + | |[[CDH1]]||16q22.1||[[familial gastric carcinoma]]||[[gastric]] |
| + | |- |
| + | |[[CDK4]]||12q14||[[familial malignant melanoma]]||[[melanoma]] |
| + | |- |
| + | |[[CDKN1B]]||12p13.1-p12||[[multiple endocrine neoplasia type IV]]||[[pituitary]],[[ parathyroid]] |
| + | |- |
| + | |[[CDKN2A]]||9p21||[[familial malignant melanoma]]||[[melanoma]],[[ pancreatic]] |
| + | |- |
| + | |[[CHEK2]]||22q12.1||[[familial breast cancer]]||[[breast]] |
| + | |- |
| + | |[[CYLD]]||16q12-q13||[[familial cylindromatosis]]||[[cylindroma]] |
| + | |- |
| + | |[[DDB2]]||11p12||[[xeroderma pigmentosum (E)]]||[[skin basal cell]],[[ skin squamous cell]],[[ melanoma]] |
| + | |- |
| + | |[[DICER1]]||14q32.13||[[familial pleuropulmonary blastoma or DICER1 syndrome]]||[[pleuropulmonary blastoma]] |
| + | |- |
| + | |[[EGFR]]||7p12.3-p12.1||[[familial lung cancer]]||[[NSCLC]] |
| + | |- |
| + | |[[ERCC2]]||19q13.2-q13.3||[[xeroderma pigmentosum (D)]]||[[skin basal cell]],[[ skin squamous cell]],[[ melanoma]] |
| + | |- |
| + | |[[ERCC3]]||2q21||[[xeroderma pigmentosum (B)]]||[[skin basal cell]],[[ skin squamous cell]],[[ melanoma]] |
| + | |- |
| + | |[[ERCC4]]||16p13.3-p13.13||[[xeroderma pigmentosum (F)]]||[[skin basal cell]],[[ skin squamous cell]],[[ melanoma]] |
| + | |- |
| + | |[[ERCC5]]||13q33||[[xeroderma pigmentosum (G)]]||[[skin basal cell]],[[ skin squamous cell]],[[ melanoma]] |
| + | |- |
| + | |[[EXT1]]||8q24.11-q24.13||[[multiple exostoses type 1]]||[[exostoses]],[[ osteosarcoma]] |
| + | |- |
| + | |[[EXT2]]||11p12-p11||[[multiple exostoses type 2]]||[[exostoses]],[[ osteosarcoma]] |
| + | |- |
| + | |[[FANCA]]||16q24.3||[[Fanconi anaemia A]]||[[AML]],[[ leukaemia]] |
| + | |- |
| + | |[[FANCC]]||9q22.3||[[Fanconi anaemia C]]||[[AML]],[[ leukaemia]] |
| + | |- |
| + | |[[FANCD2]]||3p26||[[Fanconi anaemia D2]]||[[AML]],[[ leukaemia]] |
| + | |- |
| + | |[[FANCE]]||6p21-p22||[[Fanconi anaemia E]]||[[AML]],[[ leukaemia]] |
| + | |- |
| + | |[[FANCF]]||11p15||[[Fanconi anaemia F]]||[[AML]],[[ leukaemia]] |
| + | |- |
| + | |[[FANCG]]||9p13||[[Fanconi anaemia G]]||[[AML]],[[ leukaemia]] |
| + | |- |
| + | |[[FH]]||1q42.1||[[hereditary leiomyomatosis and renal cell cancer]]||[[leiomyomatosis]],[[ renal]] |
| + | |- |
| + | |[[FLCN]]||17p11.2||[[Birt-Hogg-Dube syndrome]]||[[renal]],[[ fibrofolliculomas]],[[ trichodiscomas]] |
| + | |- |
| + | |[[GPC3]]||Xq26.1||[[Simpson-Golabi-Behmel syndrome]]||[[Wilms tumour]] |
| + | |- |
| + | |[[HNF1A]]||12q24.2||[[familial hepatic adenoma]]||[[hepatic adenoma]],[[ hepatocellular carcinoma]] |
| + | |- |
| + | |[[HRAS]]||11p15.5||[[Costello syndrome]]||[[rhabdomyosarcoma]],[[ ganglioneuroblastoma]],[[ bladder]] |
| + | |- |
| + | |[[KIT]]||4q12||[[familial gastrointestinal stromal tumour]]||[[GIST]],[[ epithelioma]] |
| + | |- |
| + | |[[LMO1]]||11p15|| ||[[neuroblastoma]] |
| + | |- |
| + | |[[MAX]]||14q23|| ||[[pheochromocytoma]] |
| + | |- |
| + | |[[MEN1]]||11q13||[[multiple endocrine neoplasia type 1]]||[[parathyroid adenoma]],[[ pituitary adenoma]],[[ pancreatic islet cell]],[[ carcinoid]] |
| + | |- |
| + | |[[MLH1]]||3p21.3||[[hereditary non-polyposis colorectal cancer]],[[ Turcot syndrome]]||[[colorectal]],[[ endometrial]],[[ ovarian]],[[ CNS]] |
| + | |- |
| + | |[[MPL]]||1p34||[[familial essential thrombocythemia]]||[[MPN]] |
| + | |- |
| + | |[[MSH2]]||2p22-p21||[[hereditary non-polyposis colorectal cancer]]||[[colorectal]],[[ endometrial]],[[ ovarian]] |
| + | |- |
| + | |[[MSH6]]||2p16||[[hereditary non-polyposis colorectal cancer]]||[[colorectal]],[[ endometrial]],[[ ovarian]] |
| + | |- |
| + | |[[MUTYH]]||1p34.3-1p32.1||[[adenomatous polyposis coli]]||[[colorectal]] |
| + | |- |
| + | |[[NBN]]||8q21||[[Nijmegen breakage syndrome]]||[[NHL]],[[ glioma]],[[ medulloblastoma]],[[ rhabdomyosarcoma]] |
| + | |- |
| + | |[[NF1]]||17q12||[[neurofibromatosis type 1]]||[[neurofibroma]],[[ glioma]] |
| + | |- |
| + | |[[NF2]]||22q12.2||[[neurofibromatosis type 2]]||[[meningioma]],[[ acoustic neuroma]] |
| + | |- |
| + | |[[PALB2]]||16p12.1||[[Fanconi anaemia N]],[[ breast cancer susceptibility]]||[[Wilms tumour]],[[ medulloblastoma]],[[ AML ]],[[breast]] |
| + | |- |
| + | |[[PDGFRA]]||4q11-q13||[[familial gastrointestinal stromal tumour]]||[[GIST]] |
| + | |- |
| + | |[[PHOX2B]]||4p12||[[familial neuroblastoma]]||[[neuroblastoma]] |
| + | |- |
| + | |[[PMS1]]||2q31-q33||[[hereditary non-polyposis colorectal cancer]]||[[colorectal]],[[ endometrial]],[[ ovarian]] |
| + | |- |
| + | |[[PMS2]]||7p22||[[hereditary non-polyposis colorectal cancer]],[[ Turcot syndrome]]||[[colorectal]],[[ endometrial]],[[ ovarian]],[[ medulloblastoma]],[[ glioma]] |
| + | |- |
| + | |[[POLE]]||12q24.3|| ||[[colorectal cancer susceptibility]] |
| + | |- |
| + | |[[PRF1]]||10q22|| ||[[various leukaemia]],[[ lymphoma]] |
| + | |- |
| + | |[[PRKAR1A]]||17q23-q24||[[Carney complex]]||[[myxoma]],[[ endocrine]],[[ papillary thyroid]] |
| + | |- |
| + | |[[PTCH1]]||9q22.3||[[nevoid basal cell carcinoma syndrome]]||[[skin basal cell]],[[ medulloblastoma]] |
| + | |- |
| + | |[[PTEN]]||10q23.3||[[Cowden syndrome]],[[ Bannayan-Riley-Ruvalcaba syndrome]]||[[harmartoma]],[[ glioma]],[[ prostate]],[[ endometrial]] |
| + | |- |
| + | |[[RB1]]||13q14||[[familial retinoblastoma]]||[[retinoblastoma]],[[ sarcoma]],[[ breast]],[[ small cell lung carcinoma]] |
| + | |- |
| + | |[[RECQL4]]||8q24.3||[[Rothmund-Thompson syndrome]]||[[osteosarcoma]],[[ skin basal cell]],[[ skin sqamous cell]] |
| + | |- |
| + | |[[RET]]||10q11.2||[[multiple endocrine neoplasia 2A/2B]]||[[medullary thyroid]],[[ papillary thyroid]],[[ pheochromocytoma]] |
| + | |- |
| + | |[[SBDS]]||7q11||[[Schwachman-Diamond syndrome]]||[[AML]],[[ MDS]] |
| + | |- |
| + | |[[SDHAF2]]||11q12.2||[[familial paraganglioma]]||[[paraganglioma]] |
| + | |- |
| + | |[[SDHB]]||1p36.1-p35||[[familial paraganglioma]]||[[paraganglioma]],[[ pheochromocytoma]] |
| + | |- |
| + | |[[SDHC]]||1q21||[[familial paraganglioma]]||[[paraganglioma]],[[ pheochromocytoma]] |
| + | |- |
| + | |[[SDHD]]||11q23||[[familial paraganglioma]]||[[paraganglioma]],[[ pheochromocytoma]] |
| + | |- |
| + | |[[SETBP1]]||18q21.1||[[Schinzel-Giedion syndrome]]||[[neuroepithelial tumours]] |
| + | |- |
| + | |[[SMAD4]]||18q21.1||[[juvenile polyposis]]||[[gastrointestinal polyp]] |
| + | |- |
| + | |[[SMARCB1]]||22q11||[[rhabdoid predisposition syndrome]]||[[malignant rhabdoid]] |
| + | |- |
| + | |[[SMARCE1]]||17q21.2|| ||[[meningioma]] |
| + | |- |
| + | |[[STAT3]]||17q21.31|| ||[[paediatric large granular lymphocytic leukaemia]] |
| + | |- |
| + | |[[STK11]]||19p13.3||[[Peutz-Jeghers syndrome]]||[[jejunal hamartoma]],[[ ovarian]],[[ testicular]],[[ pancreatic]] |
| + | |- |
| + | |[[SUFU]]||10q24.32||[[medulloblastoma predisposition]]||[[medulloblastoma]] |
| + | |- |
| + | |[[TERT]]||5p15.33|| ||[[melanoma]] |
| + | |- |
| + | |[[TP53]]||17p13||[[Li-Fraumeni syndrome]]||[[breast]],[[ sarcoma]],[[ adrenocortical carcinoma]],[[ glioma]],[[ multiple other tumour types]] |
| + | |- |
| + | |[[TSC1]]||9q34||[[Tuberous sclerosis 1]]||[[hamartoma]],[[ renal cell carcinoma]],[[ tuberous sclerosis tuber]] |
| + | |- |
| + | |[[TSC2]]||16p13.3||[[Tuberous sclerosis 2]]||[[hamartoma]],[[ renal cell carcinoma]],[[ tuberous sclerosis tuber]] |
| + | |- |
| + | |[[TSHR]]||14q31|| ||[[thyroid adenoma]] |
| + | |- |
| + | |[[VHL]]||3p25||[[Von Hippel-Lindau syndrome]]||[[renal]],[[ haemangioma]],[[ pheochromocytoma]] |
| + | |- |
| + | |[[WAS]]||Xp11.23-p11.22||[[Wiskott-Aldrich syndrome]]||[[lymphoma]] |
| + | |- |
| + | |[[WRN]]||8p12-p11.2||[[Werner syndrome]]||[[osteosarcoma]],[[ meningioma]],[[ other tumour types]] |
| + | |- |
| + | |[[WT1]]||11p13||[[Denys-Drash syndrome]],[[ Frasier syndrome]],[[ familial Wilms tumour]]||[[Wilms tumour]] |
| + | |- |
| + | |[[XPA]]||9q22.3||[[xeroderma pigmentosum (A)]]||[[skin basal cell]],[[ skin squamous cell]],[[ melanoma]] |
| + | |- |
| + | |[[XPC]]||3p25||[[xeroderma pigmentosum (C)]]||[[skin basal cell]],[[ skin squamous cell]],[[ melanoma]] |
| + | |
| | | |
| |} | | |} |